Agilent closes $1.2B senior notes offering to finance BioVectra acquisition

AGILENT TECHNOLOGIES, INC.

Issued $600M 4.200% notes due 2027 and $600M 4.750% notes due 2034 at 99.866% and 99.638% of par, respectively.
Proceeds to fund BioVectra acquisition; 2027 notes subject to mandatory redemption at 101% if deal not closed.
Notes are unsecured senior obligations ranking equally with other senior unsecured debt.
Redemption available before Par Call Dates with make-whole premium of 10bps (2027) or 20bps (2034).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.